Inotropic and lusitropic effects induced by the inhibitory factor of the Na/Ca exchanger are not mediated by the beta-adrenergic activation.
Shpak
Beni
B
Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv 69978, Israel.
Shpak
Chagit
C
Hiller
Reuben
R
Boyman
Liron
L
Khananshvili
Daniel
D
D058665:Adrenergic beta-1 Receptor Agonists; D058671:Adrenergic beta-1 Receptor Antagonists; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D016275:Atrial Function / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007537:Isometric Contraction / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D018342:Receptors, Adrenergic, beta-1 / Q000502:physiology; D012508:Sarcolemma / Q000187:drug effects / Q000502:physiology; D019831:Sodium-Calcium Exchanger / Q000037:antagonists & inhibitors* / Q000494:pharmacology / Q000502:physiology; D013045:Species Specificity; D013268:Stimulation, Chemical; D016276:Ventricular Function
D058665:Adrenergic beta-1 Receptor Agonists; D058671:Adrenergic beta-1 Receptor Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D018342:Receptors, Adrenergic, beta-1; D019831:Sodium-Calcium Exchanger; C110374:sodium-calcium exchanger 1; D011433:Propranolol; D007545:Isoproterenol